Trial intelligence / Profile preview

Rebamipide in Dry Eye

NCT00201955Phase 3Completed

Sponsor
Otsuka Pharmaceutical Development & Commercialization
Start
May 2004
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of rebamipide ophthalmic solution in keratoconjunctivitis sicca (KCS), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started May 2004; status: completed.

02

Drugs

rebamipide ophthalmic solution
03

Conditions

keratoconjunctivitis sicca (KCS)

Beyond the preview

Go deeper on NCT00201955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00201955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call